# OnCo record harbour-biomed (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/harbour-biomed/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "harbour-biomed" ;
  schema:name "Harbour BioMed"@en ;
  schema:alternateName "Harbour BioMed (Guangzhou) Co. Ltd."@en, "HBM"@en ;
  schema:description "Harbour BioMed is a Hong Kong-listed antibody company, with operations in China, the Netherlands and the United States, whose fully human and heavy-chain-only antibody platforms feed cancer immunotherapy programmes and phase 3 trials."@en ;
  schema:url <https://onco.cc/companies/harbour-biomed/>, <https://www.harbourbiomed.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.harbourbiomed.com>, <https://clinicaltrials.gov/search?lead=Harbour%20BioMed%20(Guangzhou)%20Co.%20Ltd.>, <https://www.wikidata.org/wiki/Q107517856> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "NL" ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .
